DSGN · CIK 0001807120 · operating
Design Therapeutics, Inc. (DSGN) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $583 million, Design Therapeutics, Inc. is a small-cap company. The stock currently trades at $10.23, down 2.01% today, with a 52-week range of $2.60–$11.14.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-0.88 | $-0.88 | +26.1% | |
| 2023 | $-1.19 | $-1.19 | -4.4% | |
| 2022 | $-1.14 | $-1.14 | — | |
| 2021 | — | — | — |